Liječnički vjesnik, Vol. 138 No. 9-10, 2016.
Stručni rad
CLINICAL RECOMMENDATIONS FOR DIAGNOSIS, TREATMENT AND MONITORING OF PATIENTS WITH ESOPHAGEAL AND ESOPHAGOGASTRIC JUNCTION CANCERS
Vesna Bišof
Antonio Juretić
Dinko Stančić-Rokotov
Nadan Rustemović
Damir Miletić
Marijo Boban
Tomislav Omrčen
Jasminka Jakić Razumović
Ira Pavlović
Ana Fröbe
Mislav Čonkaš
Zoran Rakušić
Damir Gugić
Sažetak
Esophageal and esophagogastric junction cancers comprise histologically and biologically different malignant tumors in which the progress in the understanding of the disease has not been followed by the improvement in the survival. Diagnosis is set by tumor biopsy during endoscopy. Multimodal approaches containing surgery, radiotherapy and chemotherapy are frequently applied in the treatment of locoregionally advanced disease. However, the optimal sequence of the treatment options is still the issue of numerous clinical trials and meta-analyzes. Metastatic disease is treated with palliative chemotherapy and best supportive care. Treatment decisions should be individualized according to patients’ characteristics and made after multidisciplinary team discussion. The following text presents the clinical guidelines in order to standardize the diagnostic procedures, treatment and monitoring of patients with esophageal and esophagogastric junction cancers in the Republic of Croatia.
Ključne riječi
Esophageal neoplasms – classifi cation, diagnosis, pathology, therapy; Esophagogastric junction – pathology; Stomach neoplasms – diagnosis, pathology, therapy; Combined modality therapy – methods; Neoplasm staging; Neolasm metastasis; Medical oncology – standards; Practice guidelines as topic – standards; Follow-up studies; Croatia
Hrčak ID:
172884
URI
Datum izdavanja:
2.11.2016.
Posjeta: 3.343 *